Nigeria and five other African countries have been selected by the Workd Health Organisation (WHO), to receive its needed technology to establish mRNA vaccine production in Africa. The countries; Egypt, Kenya, Senegal, South Africa, Tunisia and Nigera would be able to produce the mRNA vaccine which was a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response.
The vaccine delivers molecules of antigen-encoding mRNA into immune cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer cell . These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells.
The mRNA is delivered by a co-formulation of the RNA encapsulated in lipid nanoparticles that protect the RNA strands and help their absorption into the cells. WHO Director-General, Dr TedrosAdhanom Ghebreyesus whomadetheannouncementat the European Union – African Union summit in Brussels on Friday, explained that the six countries all applied and added that the technology needed to produce mRNA vaccines on the African continent. The announcement was made at a ceremony hosted by the European Council, France, South Africa and WHO in the presence of President Macron, President Ramaphosa, the President of the European Council, Charles Michel and the President of the European Commission, Ursula von der Leyen.